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The induction ofserum or mucosal antibody responses to orally administered
antigens is often difficult and generally requires the administration of relatively
large quantities of antigen, as the amount of antigen that is actually absorbed
and capable of eliciting an immune response is usually low . As a consequence,
the amount of antigen required for oral immunization generally far exceeds that
required for parenteral induction of systemic immunity . Furthermore, the oral
presentation of the large quantities of antigen required to produce an immune
response often leads to the simultaneous induction of systemic tolerance (1-7) .
Evidence to date suggests that in general the mechanism by which antigen is
taken up by the small intestine is primarily via nonspecific sampling of the
contents of the gut lumen by M cells that overlie the Peyer's Patches and other
lymphoid clusters of the gut-associated lymphoid tissue (GALT)' (8) . The sub-
sequent sensitization of local lymphocyte populations leads to the generation of
local IgA immune responses plus the sensitization of IgG and IgE suppressor
cells with concomitant suppression of serum IgG and IgE responses (1-7) .
During some recent experiments (unpublished observations), we noticed that
feeding mice small quantities of Escherichia coli pili elicited both a significant
serum antibody response to the pili, as well as a concomitant response in the
intestine . Feeding similar quantities of BSA did not elicit any such antigen-
specific serum or intestinal response .
The question arose then as to whether there exist any other antigens apart
from the E . coli pili that exhibit the ability to specifically prime the mucosal
immune system upon oral administration and/or to stimulate the humoral
immune response in a dose-dependent manner, without inducing systemic tol-
erance and without the need for excessive doses of antigen .
With this objective in mind we decided to investigate the potential of certain
adhesive molecules, which have been implicated in the initial attachment of a
number of intestinal pathogens, to stimulate the immune response when orally
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￿
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pylthio-n-D-galactopyranoside ; LB, Luria broth ; LTB, labile toxin B subunit .
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administered. The surface antigens that confer adhesive properties to a number
of strains of enterotoxigenic E. coli (ETEC) have been identified as nonflagellar,
filamentous proteinaceous appendages, called fimbrae or pili (9). Examples
include the CFA I and CFA II pili of human ETEC strains and the K88, K99,
F41 and 987P pili of animal ETEC strains (10-14). In addition, we have
examined the ability of a number of other proteins that have no apparent role
in colonization to prime the immune system upon oral feeding. These antigens
included a number of lectins, a serotypic antigen of Salmonella typhimurium (the
type i flagella), inactivated flu virus, and S. typhimurium endotoxin (LPS). Oral
priming was compared to the response generated by wholly intramuscular
challenge .
In the course of these studies we have been able to identify classes of antigens
that when orally administered to an animal at low doses were effectively taken
up by the cells of the gastrointestinal mucosa and were then able to elicit serum
and/or secretory antibodies without the induction of systemic tolerance.
Materials and Methods
Materials.
￿
The various lectins and BSA were purchased from Sigma Chemical Co., St.
Louis, MO. Inactivated influenza vaccine was purchased from the Commonwealth Serum
Laboratories (Melbourne, Australia).
Bacterial Strains and Media.
￿
E. coli strains overproducing K99, 987P, or the E. coli
labile toxin B subunit (LTB) were constructed at Biotechnology Australia Pty. Ltd., and
were the generous giftsof Dr. Susan Clark. Cultures were grown at 37°C with shaking in
Luria broth (LB). The strain expressing LTB was induced with 1 mM isopropylthio-n-D-
galactopyranoside (IPTG). S. typhimurium was grown at 37°C with shaking in LB plus
0.2% glycerol.
Pili Preparation.
￿
E. Coli cells expressing pili were harvested during the logarithmic
phase of growth. Cultures were heated at 60°C for 30 min, after which the cells were
pelleted by centrifugation (3,000 g, 30 min, 4° C). The supernatant was examined for pili
content by 12.5% SDS-PAGE using a modification of the method of Laemmli (15, 16).
K99 pili were purified by adjusting the culture supernatant to pH 9.7 with 10 N NaOH
and stirring at room temperature (RT) for 10 min. The resultant precipitate containing
pili was recovered by centrifugation (3,000 g, 30 min 4° C) and resuspended in 100 ml
distilled water (dH20) and the pH was lowered to 7.2 using 1 N HCl. This procedure was
repeated twice.
987P pili were purified as detailed above except that pili precipitation was achieved by
adjusting the pH to 3 .9 with glacial acetic acid.
Hydroxyapatite Chromatography.
￿
Hydroxyapatite (HA) (DNA grade Bio-Gel HTP; Bio-
Rad Laboratories, Richmond, CA) was gently swollen in an excess of dH20 and after a
brief period (<2 min) fines were decanted gently. Fresh dH20 was added and used to
gently resuspend the gel, after which fines were decanted again. This procedure was
repeated several times. A column (30 x 5 cm) was filled with a slurry of ^-30% HA and
allowed to settle by gravity. Tight packing was then achieved by passing dH20 through
the column at a flow rate of 16 ml/h until the gel bed surface was stationary. Samples
(100 ml) of either K99 or 987P pili were applied at flow rates not exceeding 30 ml/h.
The column was then washed with dH20 until no protein was detected in the flow through
at 280 nm. Pili were eluted at a flow rate of 30 ml/h using a linear gradient of 15-250
mM sodium phosphate buffer, pH 7 .5. Fractions were collected and examined by SDS-
PAGE. The pilus peak was recovered and pooled.
Pooled fractions of the K99 and 987P pili after HA chromatography were reprecipitated
with NaOH (by adjusting to pH 9.7) or glacial acetic acid (adjusting to pH 3.9) respectively.
After centrifugation (3,000 g, 10 min), the pellets containing pili were resuspended in 50
mM citrate buffer, pH 5.5 (K99 pili) or 50 mM Tris-HCl, pH 8.5 (987P pili), before442
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loading on the ion-exchange columns equilibrated with the same buffers. K99 and 987P
pili were loaded onto carboxymethyl (CM) and DEAE columns respectively at a flow rate
of 100 ml/h, washed with 2 volumes of loading buffer and the pili were eluted using a
linear gradient from 10 mM to 0.5 M NaCl in the equilibration buffers. Fractions were
examined by SDS-PAGE for protein content and LPS contamination, according to the
method of Tsai and Frasch (17).
LTB Purification.
￿
3 liters of culture supernatant were diluted to 6 liters with dH20.
The pH was adjusted to 6 .5 with glacial acetic acid and loaded onto a 5 x 30 cm column
of fast-flow CM-Sepharose equilibrated with 10 mM phosphate buffer, pH 6.5, at a flow
rate of 1 .2 1/h. The column was then washed with 400 ml of 10 mM phosphate buffer,
pH 6.5, and bound protein was eluted with a linear gradient of 10-500 mM NaCl in 10
mM phosphate, pH 6 .5. Fractions were collected and analyzed by SDS-PAGE, and the
LTB peak was pooled. Finally the LTB pool was loaded onto a column ofp-aminophenyl-
B-D-thiogalactopyranoside-agarose, previously equilibrated with distilled water. After ex-
tensive washing, the LTB was eluted from the column with 0.1 M galactose. Afterdialysis,
the LTB was lyophilized.
Flagella Isolation and Purification.
￿
Late log-phase cultures of bacteria (expressing both
i and 1,2 flagellae) were pelleted by centrifugation (3,000 g for 15 min at 4°C). The cells
were resuspended in saline and heated at 60°C for 30 min, followed by centrifugation
(3,000 g, 10 min, 4 °C). The supernatant was precipitated by adding a solution of 100%
TCA (wt/vol) to give a final concentration of 10% (wt/vol) and spun for 10 min at 1,500
g at VC. C. The pellet was resuspended in a small volume of 1 M Tris, pH 8 .8, and sonicated
until dissolved. Ethanol was added to a final concentration of 80% (vol/vol) and the
flagella were spun down at 2,000g, 10 min at VC. C. The pellet was resuspended in acetone,
sonicated into suspension, and reprecipitated by centrifugation (5,000 g). Finally, the
pellet was brought into solution by boiling in 10% SDS and 50 mM EDTA in 10 mM
Tris-HCI, pH 8.0, before Sephacryl S-200 chromatography.
After boiling for 15 min the flagella were clarified by centrifugation for 5 min in a
Beckman Instruments, Inc., Fullerton, CA, benchtop microfuge to remove nonsolubilized
material. The supernatant was applied to a 2.5 x 80 cm column of Sephacryl-5200
(Pharmacia Fine Chemicals) equilibrated with 20 mM Tris, pH 8.8, 0.1% SDS, and 10
mM EDTA), and eluted using the same buffer. Fractions were collected and analyzed by
SDS-PAGE. Finally, the flagella peak was pooled and precipitated with 10% (final
concentration) TCA followed by centrifugation, and ethanol and acetone washes as
described above. The final pellet was resuspended in dH20.
LPS Purification.
￿
Overnight cultures of S. typhimurium were extracted (30 min RT)
with 0.5 M CaC12 in 20% ethanol (v/v) containing 100 mM citrate, pH 3.0, and 5%
Zwittergent 3,12 (wt/vol) (Calbiochem-Behring Corp., San Diego, CA). Bacteria were
pelleted by centrifugation (3,000 g, 10 min at 4°C) and the pellet was resuspended in 50
mM EDTA, pH 8.0. The suspension was stirred vigorously for 30 min at RT. After
removal of the bacteria by centrifugation, ethanol was added to the supernatant to a final
concentration of 75% . Protein material was pelleted and the supernatant adjusted to 90%
ethanol. The precipitate that formed was pelleted and washed with acetone, reprecipitated,
and finally resuspended in dH20 . The preparation was assayed for sugar content using
the Anthrone reagent (18) and checked for the presence of contaminating proteins using
SDS-PAGE. Commercial E. coli LPS (Sigma Chemical Co.) was used as a standard in both
assays. Gels were stained for LPS using a silver stain according to the method of Tsai and
Frasch (17).
Preparation of Polysaccharide (PS).
￿
Lipid A was cleaved from the S. typhimurium LPS
preparation by incubating the LPS with 1 M glacial acetic acid and heating at 100°C for
3 h. Lipid A was then removed by centrifugation at 3,000 g for 10 min at 4°C. The
supernatant was then lyophilized.
Description of Purified Antigens.
￿
SDS-PAGE analysis of purified K99 and 987P pili
preparations revealed the presence of a single band migrating at 17,500 and 20,000 mol
wt, respectively, under reducing conditions (Fig. 1). This agrees with the published data
of Isaacson and others (19-22). The ease of precipitation of these proteins at pH 9.7 andAIZPURUA AND RUSSELLJONES
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FIGURE 1 . SDS-PAGE anal-
ysis of purified antigens . Puri-
fied proteins were examined
by SDS-PAGE using a 14%
polyacrylamide gel . LTB
eluted from CM-Sepharose (a,
lane 1) was passed down a col-
umn ofagthio-galactose-Seph-
arose (Sigma Chemical Co .)
and eluted with 0 .1 M galac-
tose. The flow-through con-
tained no LTB (lane 2), while
the B was eluted by galactose
as a single protein band (lane
3, 50 ug) . Purified 987P and
K99 pili and flagella are shown
in b (lanes 4-6, respectively ;
25 jug) . Bio-Rad Laboratories
low-molecular weight mark-
ers are shown, with molecular
weights (X 10- ') .
3.9 (for K99 and 987P, respectively) suggests that the pl of these two proteins is around
these ranges (see references 19, 21) . Silver staining of the preparations showed them to
contain little (<1 lAg/100 wg protein) or no contamination with LPS .
Purified LTB and S. typhimurium flagella were also found to be free of contaminating
LPS and to travel as monomers of apparent molecular weights of 12,500 and 52,000,
respectively, when examined by SDS-PAGE under reducing conditions (Fig . 1) . The
flagellae preparation was found to be contaminated by a second, slower migrating band,
which was found to be the alternate 1,2 flagellar phase . The main band was the i phase
(results obtained by Western blot analysis and not shown here) .
Silver-stained SDS-PAGE gels of purified LPS revealed no detectable protein contam-
ination . Complex sugar content, as assayed by Anthrone reaction, was found to be 2 mg/
ml . Lipid A-free polysaccharide was also found to contain 2 mg/ml polysaccharide and
its failure to move on SDS-PAGE (as revealed in silver-stained gels) showed it to be free
of contaminating lipid .
Determination of the 987P Pilus NH2-Terminal Sequence .
￿
NH2-terminal micro-sequenc-
ing was performed for us by Biotechnology Research Enterprises S.A . Pty . Ltd ., Adelaide,
South Australia . A 100 nmol sample of 987P pili purified as described above was assayed .
The NH2-terminal sequence of 987P is compared with the published sequence of a
number of other published sequences and reveals no homology between it and the other
molecules (Fig . 2) (9).
Dinitrophenylation of Antigens .
￿
K99 pili, LTB, and lectins were dinitrophenylated
according to the method of Little and Eisen (23) . Briefly, carriers (in 0.1 M sodium
carbonate/bicarb buffer, pH 9.5) were reacted with a 0.1 M solution of dinitrofluoroben-
zene (DNFB, Sigma Chemical Co .) in acetone overnight at RT . The proteins were then
dialyzed extensively against the coupling buffer . Previous studies by us have shown that
987P pili have no free amino groups exposed for coupling so a diamino spacer was first
linked to the free carboxyl moieties of the protein as follows : 10 mg of purified 987P pili
were precipitated at pH 3.9 by the addition of glacial acetic acid . The pili were removed
by centrifugation at 3,000 g, 10 min at 4°C . The pellet was resuspended in clH 20 and
the pH raised to 6.5 with 1 N NaOH . The pilus solution was then reacted with 1-ethyl-3-
(3-dimethylaminopropyl)-carbodiimide-HCI (EDAC ; Bio-Rad Laboratories, Richmond,
CA), to a final concentration of 0.5 mM in the presence of 20 mM 1,2-diaminoethane,
pH 6 .5 (BDH Chemicals Ltd ., Poole, England), overnight at room temperature (20-
23°C) . The amino-substituted 987P pili were dialyzed for 24 h against two changes of444
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1
￿
5
￿
10
Type 1
￿
Ala -Ala -Thr-Thr-Val -Asn-Gly -Gly -Thr-Val-His -Phe -Lys -Gly -
K88
￿
Trp-Met-Thr-Gly-Asp -Phe-Asn-Gly-Ser-Val-Asp -Ile -Gly-Gly-
K99
￿
Asn-Thr-Gly -The-Ile -Asn-Phe -Asn -Gly -Lys-Ile -Thr-Ser -Ala -
987P
￿
Ala -Pro -Val -Glu -Asn-Asn-Thr-Cys -Gln -Ala-Asn-Leu-Asp-Phe-
Neisseria
￿
Phe -Thr-Leu-Ile -Glu -Leu-Met-Ile -Val -Ile -Ala -Ile -Val -Gly -
15
￿
20
￿
25
Type 1
￿
Glu -Val -Val -Asn-Ala -Ala-
K88
￿
Ser -Ile -Thr-Ala -Asp-Asp-Tyr-Arg-
K99
￿
Thr-Cys-Thr-Ile -Glu -Pro-Glu -Ala -
987P
￿
Thr-Gly -Lys -Val -Thr-Ala x -Leu-
Neisseria
￿
Ile -Leu-Ala -Ala -Val -Ala-Leu-Pro -
FIGURE 2.
￿
NH2-terminal aminoacid sequence of the 987P pilin subunit. The NH2-terminal
sequences of otherpilin proteins are given forcomparison.
0.1 M carbonate/bicarbonate buffer, pH 9.5, before being used in the subsequent
conjugation steps. Lectin binding sites were protected during their reaction with DNFB
by the addition of the lectin-specific sugars. Thus, 50 mM solutions of D-glucose, D-
mannose, N-acetyl-D-galactosamine, D-galactose, N-acetyl-D-galactosamine, D-gal(I-3)-D-
ga1N-Ac, and L-fucose, were added to lectins from the following sources: ConA, PWM,
Lens culinaris, Helix pomatia, Glycinemax, Arachis hypogea and Ulex europeus, respectively.
Antigen Administration.
￿
Female C57BL/6J mice (18-22 g) were obtained from the
Animal Resources Center (Perth, Western Australia). All mice were starved for 3-4 h
before oral or intramuscular administration of antigens. Mice were fed antigen at appro-
priate concentrations in 0.5 ml of 0.1 M carbonate/bicarbonate buffer, pH 9.5, using a
speciallyprepared feeding needle. Parallel doses ofantigenwere injected intramuscularly,
in 0.1 ml of sterilephysiological saline, into theleft hind leg. Groups of five mice receiving
antigen either orally or intramuscularly were given two identical doses of antigen, on day
0 and day 14. A blood sample was taken (^-0.5 ml) from the retro-orbital plexus on day
14 and day 21 . Mice were then killed by cervical dislocation and gut washes performed
on the small intestine in the following manner. The small intestine was carefully removed
and 1 ml of washing buffer (30 mM Tris-HCI, pH 8.8, 0.9% NaCl, 50 mM EDTA plus
1.0% Tween 20) introduced into the lumen of the gut via a blunt-ended feeding needle.
After gently kneading the intestine, the contents were squeezed out through forefinger
and thumb. Gut washes so obtained were immediately centrifuged to remove debris and
stored at -20°C until assayed. Blood samples were allowed to clot at 4°C before removal
of the serum and storage at -20°C.
Inhibition of the Immune Response by Cofeeding-specific Sugars.
￿
A number of sugars were
tested for their ability to inhibit the immune response generated when the mucosal
immunogens were administered orally. Immediately before feeding, LTB, 987P and K99
pili were mixed with 25 jmol of the various sugars. Mice were then fed, bled, and sera
were assayedas described previously.
Enzyme-linked Immunosorbent Assay (ELISA). The ELISA for the determination of
antibody titers was performed as described previously by RussellJones et al. (24). The
assay was standardized so that 1 jig of specific antibody produced an ELISA titer of 10'
while 1 mg of specific antibody gave a titer of 10e.
Results
Identification of Molecules Active as Mucosal Immunogens.
￿
The potential of a
number of molecules to stimulate the production of an immune response after
oral administration was examined. The response generated by molecules with
known binding activities was compared with the response seen after similar
feeding of other molecules having no known mucosal binding functions.AIZPURUA AND RUSSELLJONES
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TABLE I
Immune Reactions to Orally Presented Antigens
* The reciprocal of the antiserum dilution that gave an ELISA readingof 0.5 after 45 minat 37°C.
Each value represents the mean value obtained from 5 mice ± I SD. A titer of i in 1,000
corresponds to I gg of specific antibody per milliliter of serum.
Each lectin was substituted with four DNP molecules/mole lectin. The antilectin response could
not be measured directly, as sugar-specific binding to IgG interfered with the ELISA, and so the
anti-DNP response is represented. Intestinal antibody titers were not measured for lectin-immu-
nized animals (ND).
As can be seen in Table I, all ofthe proteins known to possess receptor binding
activities were capable of eliciting serum antibody responses upon oral presen-
tation. Thus K99 and 987P pili (bacterial adhesins), LTB (the GM-1-binding
subunit ofE. coli heat-labile toxin), the various lectins, as well as the inactivated
flu vaccine (in which the hemagglutinin activity was still maintained), all elicited
comparable serum antibody responses at the doses tested (Table I). This class of
proteins will henceforth be referred to as mucosal immunogens. The marginally
lower response elicited by the inactivated flu vaccine presumably reflects the
smaller amount of hemagglutinin present in this preparation, as it is not a
purified hemagglutinin vaccine but rather a whole virus preparation. Variable
stimulation of intestinal antibodies occurred, but was only present upon feeding
of the mucosal immunogens.
None ofthe other antigens tested were capable ofeliciting a substantial serum
response at the doses tested. Intramuscular injection of five of the proteins
stimulated very similar antibody titers regardless of whether the protein was
effective as a mucosal immunogen or not (Table II). Thus the serum titers to
intramuscularly injected K99, 987P pili or LTB (all mucosal immunogens) varied
little from that elicited by the intramuscular injection of flagellin or BSA (both
shown to be ineffective orally).
Dose-response experiments comparing oral with intramuscular administration
Antigen used for
immunization
(20-iAgdose)
Serum
IgG
immune response* (day 21)
IgA IgG
Intestinal
IgA
K99 pili 968 ± 120 <4 3.0 ± 5.2 3.2 ± 4.9
987P pili 776 ± 64 10.8 t 8.8 10.9 ± 1.7 48.5 ± 1.88
LTB 1,351 ± 211 <4 <4 12.2 ± 4.4
Fluvaccine 179 ± 34 <4 <4 <4
Flagella <4 <4 <4 <4
LPS 12.1 ± 1.0 <4 <4 <4
Polysaccharide <4 <4 <4 <4
BSA <4 <4 <4 <4
Con A$ 666 ± 84 <4 ND ND
PW-mitogent 641 ± 119 <4 ND ND
L. culinaris$ 954 ± 48 <4 ND ND
H. pomatiat 591 ± 127 <4 ND ND
P. vulgaris$ 1,378 ± 110 4.8 ± 2.3 ND ND
G. max* 1,529 ± 65 3.1 ± 6.9 ND ND
A. hypogeat 1,276 ± 242 <4 ND ND
U. europeust 1,583 t 94 <4 ND ND446
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TABLE 11
Immune Reactions to Antigens Presented Intramuscularly
Immune response* (day 21)
3"
0
of
0
e
0
O
9 2-
LPS
￿
388 f
* See Table I.
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FIGURE 3.
￿
Effect of route and dose on the immune response to K99 pili (O, *), 987P pili
(A,A) and LTB(0, /). Each antigen was injected intramuscularly (open symbols), or presented
orally (filled symbols). Antibody titers are given as the serum IgG response (-); and the
intestinal IgA response (-- -). Results are shown for the day 21 response and are expressed
as the mean antibody titerof five mice.
of K99 or 987P pili or LTB revealed that oral presentation of these antigens
was remarkably efficient in eliciting a serum antibody response, as the response
generated was only slightly lower than the intramuscular injection of the same
antigens. High doses of each of these proteins were required to elicit significant
intestinal antibody responses (Fig. 3).
Inhibition of the Immune Response to Oral Immunogens by Cofeeding Sug-
ars. Stimulation of the immune response to orally presented LTB and K99 was
completely abolished by cofeeding galactose or other molecules with close struc-
Antigen used
for immuni-
zation
(dose) IgG
K99 pili 1,024 ±
987P pili 1,552 ±
LTB 1,782±
Flagella 1,595 ±
Serum
IgA
Intestinal
IgG IgA
94 <4 <4 <4
112 <4 <4 <4
100 <4 <4 <4
227 <4 <4 <4
58 <4 <4 <4AIZPURUA AND RUSSELLJONES
￿
447
TABLE III
Inhibition of the Immune Response to Orally Administered Antigen by
Cofeeding Certain Sugars
A 20-Wg dose of LTB or 987P or K99 pili was premixed with various
sugars before feeding. Results representthemean ELISAtiters ofserum
of five mice. The serum response to theseantigens is given.
* See Table I.
tural homology to galactose, such as lactose and sorbitol (Table III). Fructose,
mannose, and melibiose did not inhibit the response to either LTB or K99 pili.
The response to 987P pili could not be inhibited by any of the sugars tested.
Discussion
In contrast to parenteral immunization, attempts to orally immunize animals
have generally involved the use of large quantities of antigen and have required
as many as 8-10 repeated feedings of milligram quantities of antigen (1-7). The
immunity induced by this regime has at best been poor, short lasting, and often
confined to the mucosal immune system. Various explanations have been put
forward for theseanomalous findings, but the most widely held belief is that oral
immunization of animals requires the antigen to be taken up by M cells of the
Peyer's patches. Antigen is then processed by resident macrophages and pre-
sented to IgA helper cells and to IgG suppressor cells (6, 8, 25, 26). The result
is the stimulation of a local IgA response and the supression of a serum IgG
response.
In this study we have shown that it is possible to effectively prime both the
systemic and intestinal immune system by feeding of low doses of some antigens.
In fact, many molecules that have the capacity to bind to the intestinal epithelium
can also be transported across the epithelial barrier, to enter the circulation and
elicit an immune response. Thus the oral feeding of two bacterial adhesins of
enterotoxigenic E. coli, K99 and 987P pili, the binding subunit of E. coli heat-
labile toxin (LTB), plus a number of lectins of varying binding specificities, were
able to stimulate significant serum antibody titers after oral administration of
the antigen (Table I and Fig. 3) . In fact, this process of uptake appeared
remarkably efficient as the response elicited to the orally presented mucosal
immunogens was only slightly lower than the response generated by intramus-
cular injections ofthe same quantities of these antigens (Fig. 3) . A slight variability
in the ability of the mucosal immunogens to elicit an intestinal response was
noted. For some reason, 987P pili stimulated a much higher intestinal response
than any of the other antigens tested over doses tested.
Sugar
(25-
AM dose)
Immune
K99 pili
Response to oral antigen
987P pili
(serum IgG)*
LTB
None 968 t 120 776 ± 64 1,351 ± 211
Fructose 1,782 ± 966 2,046 t 894 6,208 ± 1,192
Galactose 65 ± 48 1,037 ± 526 4 ± 1.0
Lactose 84 f 204 1,128 ± 662 5 ± 1.0
Mannose 1,176 ± 411 4,970 t 2,270 4,096 t 658
Melibiose 1,840 ± 208 1,243 ± 474 512 ± 76
Sorbitol 77 ± 179 1,389 t 307 8 ± 1.2448
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Feedings of similar quantities of BSA, flagella, LPS, or polysaccharide (PS)
induced no detectable antibody response either in serum or in intestinal fluid.
Binding of the mucosal imunogens to the intestinal mucosa appeared to be a
specific phenomenon as the immune response to LTB and K99 could be com-
pletely abolished by cofeeding galactose, lactose, orsorbitol, butnotbycofeeding
any of the other sugars tested (Table III). The response to 987P pili was not
affected by these sugars. The inhibition ofan immune response to LTBand K99
pili seen when these molecules were cofed with galactose, lactose, and sorbitol is
to be expected due to the similarities in structure of these compounds to
galactose, which is claimed to be the specific sugar determinant on both the GM1
ganglioside to which LTB is known tobind (27-29), and on the GM2 ganglioside
to which K99 is thought to bind (9). The receptor for 987P is yet to be
characterized. Furthermore, the abolition of the response seen with these sugars
suggests that binding to the mucosa is a specific, receptor-mediated reaction in
which the mucosal immunogens bind to specific glycoproteins or glycolipids on
the villous epithelium. In this respect, intestinal uptake of these antigens differs
significantly from the antigen sampling mechanism suggested for the uptake of
orally administered antigens (7, 8, 10, 11, 25).
It is interesting to compare these results with the work of Pierce and others
(30-34) on the oral feeding of cholera toxin. Oral administration of relatively
small quantities ofthis toxin, in the 10-100-iAg range, results in the stimulation
of relatively good antibody responses in both serum and secretions. Animals
receiving larger dosesofthis toxin exhibit all the symptomsofa cholera infection
(30). These results interalia, led to the popular notion that cholera toxin is a
potent immunogen (31, 32). It must be noted however, that parenteral admin-
istration of this molecule does not elicit antibody responses that are significantly
higher than that elicited by similar administration ofother proteins such as BSA
or keyhole limpet hemocyanin. When cholera toxoid, which is nontoxic, is orally
administered it is much less efficient in provoking an antibody response. Thus,
Pierce and Koster (33) required doses of40 mg oftoxoid to generate an immune
response to the intraduodenal administration of this antigen. These experiments
suggested that the toxicity of the intact toxin is required for its ability to prime
the immune system orally. However, experiments using only the B subunit of
cholera toxin (CTB) (34), suggest that this is not the case. Thus, when CTB was
administered without the toxic A subunit it was still effective in priming the
immune system upon oral challenge. It would seem, therefore, that the enhanced
ability ofcholera toxin to prime the immune system upon oral feeding does not
depend upon the toxicity of this molecule, but is dependent instead upon some
other property shared between it and its B subunit. The experiments described
in this paper suggest that this property may be the ability of CT and CTB to
bind to ganglioside-like molecules located onthe surface ofthe cells ofthe villous
epithelium. Pierce and coworkers(33, 34) didnotexamine theability ofgalactose
or its analogues to inhibit the ability of CT to prime the immune system upon
oral administration.
The results presented in this paper demonstrate tht it is possible to stimulate
the systemic and mucosal immune systems effectively by feeding low doses of
certain classes of proteins. These proteins all share the property ofbeingable tobind specifically to various glycolipids and glycoproteins located on the surface
of the cells of the intestinal mucosa and somehow to trigger these cells to
internalize the antigens and to transport them to the circulation. The uptake of
these molecules can be specifically inhibited by a number ofsugars. It is conceiv-
able that viral or bacterial pathogens may use this method of attachment to
adhere to and to gain entry into various cells ofthe gastrointestinal epithelium.
The possibility also exists that these mucosal immunogens can be used as carrier
proteins to transport other antigens, drugs or hormones more effectively from
the intestine into the systemic circulation. These possibilities are currently under
study.
Summary
Oral immunization of an animal is generally hard to achieve unless large
quantities of antigen are administered. In this study a number of antigens were
tested for their ability to elicit a systemic immune response upon oral adminis-
tration. It was found that bacterial pili, LTB, lectins, and a viral hemagglutinin
were all able to elicit significant antibody titers upon oral feeding. The immune
response thus generated to LTB and K99 pili could be completely abolished by
cofeeding a numberofsugars that have close structural homology to the terminal
sugars of the GMI and GM2 gangliosides to which these molecules are known
to bind. All of the proteins that were active in oral immunization are known to
possess "lectin or lectin-like" binding activities. It is therefore proposed that these
molecules are able to bind to glycolipids and glycoproteins on the intestinal
mucosa and to stimulate these cells to transport the proteins into the systemic
circulation, thereby eliciting a systemic immune response. Molecules that did not
possess this binding activity wereunable to elicit significant responsesatthe doses
tested.
Receivedfor publication 7 October 1987.
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